Emergent Biosolutions, Inc. EBS

$4.49 -1.32% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-02 View →
8-K 8-K 2026-06-29 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-06-10 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-04 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
4 FORM 4 2026-05-01 View →
10-Q 10-Q 2026-05-01 View →
8-K 8-K 2026-04-30 View →
8-K 8-K 2026-04-30 View →
8-K 8-K 2026-04-17 View →
4 FORM 4 2026-04-03 View →
DEF 14A DEF 14A 2026-03-20 View →
4 FORM 4 2026-03-06 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-03 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.49
Market Cap
$233.29 million
52-Week Range
$4.36 $14.06
Average Volume
1.08 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.